• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

AJR Am J Roentgenol . COVID-19-Related Disseminated Leukoencephalopathy (CRDL): A Retrospective Study of Findings on Brain MRI

tetano

Editor, Senior Moderator
AJR Am J Roentgenol


. 2020 Sep 9.
doi: 10.2214/AJR.20.24364. Online ahead of print.
COVID-19-Related Disseminated Leukoencephalopathy (CRDL): A Retrospective Study of Findings on Brain MRI


Colbey W Freeman[SUP] 1 [/SUP], Jonathan Masur[SUP] 1 [/SUP], Alvand Hassankhani[SUP] 1 [/SUP], Ronald L Wolf[SUP] 1 [/SUP], Joshua M Levine[SUP] 2 [/SUP], Suyash Mohan[SUP] 1 [/SUP]



Affiliations

Abstract

Among 2,820 inpatients with coronavirus disease-2019 (COVID-19), 59 (2.1%) underwent brain MRI. Of these patients, six (10.2%) had findings on MRI suspicious for COVID-19 related disseminated leukoencephalopathy (CRDL), characterized by extensive confluent or multifocal white matter lesions (with characteristics and locations atypical for other etiologies), microhemorrhages, diffusion restriction, and enhancement. CRDL is an uncommon but important differential consideration in patients with neurologic manifestations of COVID-19.
 
Back
Top Bottom